Number needed to treat (NNT) as a measure of drug benefit: Lenalidomide versus bortezomib for treatment of relapsed/refractory multiple myeloma (MM) von Kaura, Satyin, Dranitsaris, George

Volltext

Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007-13) and prospective (2014-18) MIDAS sales data analysis von Divino, Victoria, DeKoven, Mitch, Kleinrock, Michael, Wade, Rolin L, Kim, Tony, Kaura, Satyin

Volltext

Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast Cancer von Snedecor, Sonya J., PhD, Carter, John A., BA, Kaura, Satyin, MSci, MBA, Botteman, Marc F., MSc, MA

Volltext

The Value of Survival Gains in Myelodysplastic Syndromes von MacEwan, Joanna, Yin, Wes, Khan, Zeba M., Kaura, Satyin

Volltext

Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective von Dranitsaris, George, Yu, Bo, Wang, Leiping, Sun, Weili, Zhou, Yan, King, Jennifer, Kaura, Satyin, Zhang, Adams, Yuan, Peng

Volltext

The impact of generics on drug volume and expenditures in oncology: A 2005-14 MIDAS analysis von Divino, Victoria, Coyle, Katharine, Kaura, Satyin, Kleinrock, Michael, Wade, Rolin L., DeKoven, Mitch

Volltext

The value of survival gains in myelodysplastic syndromes von MacEwan, Joanna P, Yin, Wes, Kaura, Satyin, Khan, Zeba M

Volltext

Impact of novel therapies on multiple myeloma survival in the US: Current and future outcomes von Drawid, Amar, Kaura, Satyin, Kiely, Daniel, Hussein, Mohamad A., Kaman, Malik, Gilra, Nisha, Durie, Brian G.

Volltext

The Value of Survival Gains in Pancreatic Cancer from Novel Treatment Regimens von MacEwan, Joanna P., Yin, Wes, Kaura, Satyin, Khan, Zeba M.

Volltext

The Budget Impact of Orphan Drugs in the U.S.: A 2007-2013 MIDAS Sales Data Analysis von Divino, Victoria, Dekoven, Mitch, Wang, Weiying, Kleinrock, Michael, Harvey, R. Donald, Wade, Rolin L, Kaura, Satyin

Volltext

Persistence to Lenalidomide Improves Patient Outcomes While Remaining Cost-Neutral for the Treatment of Multiple Myeloma von Henk, Henry J, Kaura, Satyin, Khan, Zeba M., Teitelbaum, April

Volltext

Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical MIDAS sales data analysis von Divino, Victoria, DeKoven, Mitch, Kleinrock, Michael, Wade, Rolin L, Kim, Tony, Kaura, Satyin

Volltext

Cost-Effectiveness of Zoledronic Acid in the Management of Skeletal Metastases in Patients With Lung Cancer in France, Germany, Portugal, The Netherlands, and the United Kingdom von Joshi, Avani D., PhD, Carter, John A., BA, Botteman, Marc F., MSc, MA, Kaura, Satyin, MSci, MBA

Volltext

European Union Pharmaceutical Markets: A Case for Differential Pricing? von Towse, Adrian, Pistollato, Michele, Mestre-Ferrandiz, Jorge, Khan, Zeba, Kaura, Satyin, Garrison, Louis

Volltext

Impact of Novel Treatments on Multiple Myeloma Survival von Robinson, David, Kaura, Satyin, Kiely, Daniel, Hussein, Mohamad A., Nersesyan, Knar, Durie, Brian G.M.

Volltext

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM) von Arikian, Steven R, Binder, Gary, Gibson, Craig, Hu, X Henry, Nagarwala, Yasir, Hussein, Mohamad A., Corvino, Frank A., Lee, Jianyi, Surinach, Andy, Kaura, Satyin, Usmani, Saad

Volltext

Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma von Henk, Henry J., Teitelbaum, April, Perez, Jose Ricardo, Kaura, Satyin

Volltext

Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis von Burudpakdee, Chakkarin, Khan, Zeba M, Gala, Smeet, Nanavaty, Merena, Kaura, Satyin

Volltext

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective von Dranitsaris, George, Yu, Bo, King, Jennifer, Kaura, Satyin, Zhang, Adams

Volltext

Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study von LeBlanc, Thomas W., Gasparetto, Cristina J, Tuchman, Sascha A, Sheldon, Peter, Howson, Alexandra, Khan, Zeba M., Kaura, Satyin, Abernethy, Amy P

Volltext